loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20573 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SODIUM PHENYLBUTYRATE (1)

filter

01 HORIZON THERAP US (1)

filter

01 POWDER;ORAL (1)

filter

01 3GM/TEASPOONFUL (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;ORAL
3GM/TEASPOONFUL
BUPHENYL
USA
20573
1996-04-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20573

Looking for CTD TGA MCC DOSSIER APPLICATION 20573 1

19

Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is SODIUM PHENYLBUTYRATE, with a corresponding application number 20573 and regulatory information .

proudly manufactured in the

approval since 1996-04-30

Horizon Therapeutics's BUPHENYL POWDER;ORAL, medication with 3GM/TEASPOONFUL of SODIUM PHENYLBUTYRATE.

Post Enquiry
POST ENQUIRY